Mr. Gus P. Georgiadis has nearly forty years of executive-level healthcare experience in both health insurance and employee benefits services. His expertise encompasses the development of go-to-market strategies, as well as strategic product positioning and product/service rollout at pharmaceutical, medical device, and digital healthcare companies.

Mr. Georgiadis currently serves as the Area Chairman of the Gallagher Benefit Services operations in Pittsburgh, Pennsylvania and upstate New York. He founded Triad USA, Inc. in 1998 and served as President until 2012, when he merged the company with Gallagher Benefit Services. Before establishing Triad, Mr. Georgiadis was Executive Vice President for Highmark Blue Cross Blue Shield, one of the largest health insurers in the United States. His experience also includes the creation of multiple businesses and initiatives that today serve as national models for healthcare, including the Gateway Health Plan and the Children’s Health Insurance Program.

Mr. Georgiadis earned a political science and business degree at Westminster College and an executive leadership degree at Duke University’s Fuqua School of Business.

Dr Thomas Lundquist is President of Vital Insights LLC, which provides transformational insights for healthcare start-ups and innovators, as well as integrated health systems and health plans focused on meeting the goals of the quintuple aim and wanting to be successful under value-based contracts. An increasingly sought out consultant and advisor, through Vital Insights, Dr Lundquist provides strategic advising, business acceleration leadership, operational effectiveness evaluation and implementation and clinical transformation insight. Companies in the Vital Insights portfolio that Lundquist has worked with in 2023 and 2024 include: AdheaRx; AposHealth; BodyPort; Cancer Diagnostics of America; Carrot Health; Ceresti Health; DUOS; ECHO Simplicity; HGAN Advisors; Hopewell Health; Independent Health Associates; Kaia Health; Laguna Health; Ready, Set, Food; Redesign Health; Rescription; SecuredHealth; Spring Health; TownSquare & ValueHealth.

Dr.Lundquist is an experienced healthcare senior executive with over 25 years of progressive, strategic & fiscal leadership and operational responsibility in various healthcare sectors, working successfully in venture capital-backed start-ups, growth phase early innovative companies, front-line healthcare system operations, integrated healthcare delivery systems, pharmacy network and distribution operations, large hospital networks, staff model HMO’s, managed care organizations, large self-insured national and international employers, and state and county governmental agencies.

Lundquist has many years of proven success within Analytics, Health Informatics, Care Management, Disease Management, Medical & Pharmacy Policy, Utilization Management, Integrated Care Delivery, Quality Management (HEDIS, STARS), Total Cost of Care Management, Sales & Marketing, Network Management, Joint Ventures, Mergers & Acquisitions, Healthcare financial analysis, Value-Based Care & Innovative Payment Models. Across his diverse leadership roles, Lundquist has remained passionately committed and undeterred in pursuing the realization of what we now know as the Quintuple Aim – clinical quality improvement, payment innovation driving cost efficiency, improving health equity, and improving both provider and patient experience.

Lundquist completed his Doctor of Medicine at The Johns Hopkins University School of Medicine and his internship and residency at the Johns Hopkins Children’s Medical & Surgical Center. He received his Masters in Medical Management from Carnegie Mellon University and then joined the adjunct faculty at the H. John Heinz III School of Public Policy & Management at Carnegie Mellon University, teaching courses in Health Care Quality and Executive Leadership for seven years in the Masters in Medical Management program.

LinkedIn: https://www.linkedin.com/in/tglundquistpittsburgh/

Dr. Bruce Nash is the President of Catamount Advisors, LLC – a life sciences, board/advisory practice which seeks to support innovative companies at the governance and advisory level to achieve transformational change in health care delivery.

Most recently, he served as the Chief Physician Executive and Senior Vice President of Health and Medical Management for Blue Cross Blue Shield of Massachusetts, one of the largest independent, not-for-profit Blue Cross Blue Shield plans in the country.

Dr. Nash has held executive leadership positions for both health plans, medical groups and hospitals during his career. Prior roles include serving as the Chief Medical Officer of Capital District Physicians’ Health Plan, the President of North Adams Regional Hospital, the Vice President of Clinical Affairs, Kaiser Permanente – Northeast, and the Vice President for Medical Group Operations Improvement for the Permanente Company.

He is a board certified family physician who practiced for more than 20 years in southern Vermont. He earned a master of business administration in health sector management from the Fuqua School of Business of Duke University, a medical degree from Albany Medical College, and a bachelor of science degree from Rensselaer Polytechnic Institute. He completed his residency in family practice at Duke University.

David B. Nash, MD, MBA, is the Founding Dean Emeritus — and remains on the full-time faculty as the Dr. Raymond C. and Doris N. Grandon Professor of Health Policy — at Thomas Jefferson University’s College of Population Health (JCPH). Dr. Nash has been a hospital trustee for over 20 years and has recently completed nearly a decade as a member of the Board of Directors for Humana, Inc., one of the nation’s largest publicly traded healthcare companies.

In 2014 he joined the board of InfoMC, a leading information technology company in suburban Philadelphia. He is on the Healthcare Advisory Board for Arsenal Capital Partners in NYC and joined the board of Tract Manager, a portfolio company of Arsenal. In late 2018 he joined the board of ANI Pharmaceuticals, a publicly-traded generic drug manufacturer, headquartered in Baudette, MN.

Finally, he is a board member of FOX Rehab, a portfolio company of Blue Wolf Capital. A board-certified internist, Dr. Nash is internationally recognized for his work and has repeatedly been named to Modern Healthcare’s list of Most Powerful Persons in Healthcare.

Tim is Founder & CEO of TEN Healthcare Strategies, LLC. a company specializing in the provision of strategic and tactical business development services in the healthcare space. With over 35 years’ experience, Tim was most recently the EVP of EmblemHealth, an $8 billion not-for-profit health plan payer and provider in the New York metro area. In addition, Tim served as the president and COO of Independent Living Systems, LLC., contributing to its growth as a nationally recognized leader in long-term managed care. Other executive roles have included positions with Meridian Health Systems, now Hackensack Meridian Health, and Coventry Healthcare and USHealthcare. where he played fundamental roles in the acquisition and integration of those organizations by Aetna. Tim currently sits on the OneHome and New York University Wagner School of Health advisory boards.

Sir David spent his 40-year career in healthcare management and leadership and was awarded a knighthood in the 2017 New Year’s honours list in recognition of his services to the NHS.

David joined the NHS as a management trainee and ended his NHS career on the Board of NHS England as its chief operating officer before his retirement in 2023.

In 2022, he was named by the Health Service Journal as the fourth-most influential person in English health policy in their HSJ100 list.

In between times, his roles included chief executive of NHS Haringey and chief executive of the Whittington Hospital NHS Trust. Sir David joined the Royal Free London in July 2009 and led the hospital to foundation status in 2012, followed by the successful acquisition of Barnet and Chase Farm hospitals in 2014. During his tenure the trust was awarded the Dr Fosters NHS Hospital of the Year and was accredited as a Global Digital Exemplar. After a decade at RFL, he left to take up the position of NHS regional director for London, leading the NHS in London through the first waves of Covid-19, before moving on the national COO role.

David is now a Senior Advisor to the IHI, a Trustee of the Royal College of Radiologists, and a Senior Fellow of the Royal Society of Medicine.

Dr. Raz Winiarsky is an award-winning, board-certified orthopedic surgeon specializing in total joints and sports orthopedics. In addition to founding and growing one of the largest orthopedic practices in Brooklyn, Queens, and northern New Jersey, he is a respected visionary in the healthcare space. Dr. Winiarsky has cofounded 2 national healthcare companies that help physicians reach a more accurate diagnosis, improve patient outcomes, and reduce medical costs. The first company, Spreemo Health, is a successful referral management platform in the occupational medicine market that helps payers improve patient outcomes by reducing medical errors in radiology. The second company, Covera Health, partners with doctors to advance how quality care is defined, measured, and delivered by leveraging artificial intelligence tools to help physicians reach more accurate diagnosis and help better detect important findings.